Bone Marrow Transplant Market, By Treatment Type (Leukemia, Lymphoma, Myeloma, Myelodysplastic Syndrome, Myeloproliferative neoplasms, Aplastic Anemia, Solid Tumors, Sickle cell anemia, Thalassemia, Others), By End User (Hospitals, Multi-Specialty Clinics

Bone Marrow Transplant Market, By Treatment Type (Leukemia, Lymphoma, Myeloma, Myelodysplastic Syndrome, Myeloproliferative neoplasms, Aplastic Anemia, Solid Tumors, Sickle cell anemia, Thalassemia, Others), By End User (Hospitals, Multi-Specialty Clinics, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Bone marrow transplant is the replacement of damaged cells with healthy stem cells and helps human body to produce optimum levels of white blood cells, platelets, or red blood cells to avoid infections, bleeding disorders, and others. Bone marrow constitutes of blood forming stem cells known as hematopoietic stem cells (HSCs). According to the Center for International Blood & Marrow Transplant Research (CIBMTR) reports 22,863 HCTs (Hematopoietic Cell Transplantation) performed in the U.S. in 2017
Key features of the study:
This report provides in-depth analysis of the Bone Marrow Transplant market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Bone Marrow Transplant market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Lonza Group Ltd., Merck Millipore Corporation, Sanofi-Aventis LLC, AllCells LLC, STEMCELL Technologies, and American Type Culture Collection (ATCC) Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Bone Marrow Transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Bone Marrow Transplant market
Detailed Segmentation:
None Marrow Transplant Market, By Treatment Type:
Leukemia
Lymphoma
Myeloma
Myelodysplastic Syndrome
Myeloproliferative neoplasms
Aplastic Anemia
Solid Tumors
Sickle cell anemia
Thalassemia
Others
None Marrow Transplant Market, By End User:
Hospitals
Multi-Specialty Clinics
Ambulatory Surgical Centers
None Marrow Transplant Market, By Region:
North America
By Treatment Type:
Leukemia
Lymphoma
Myeloma
Myelodysplastic Syndrome
Myeloproliferative neoplasms
Aplastic Anemia
Solid Tumors
Sickle cell anemia
Thalassemia
Others
By End User
Hospitals
Multi-Specialty Clinics
Ambulatory Surgical Centers
By Country:
U.S.
Canada
Latin America
By Treatment Type:
Leukemia
Lymphoma
Myeloma
Myelodysplastic Syndrome
Myeloproliferative neoplasms
Aplastic Anemia
Solid Tumors
Sickle cell anemia
Thalassemia
Others
By End User
Hospitals
Multi-Specialty Clinics
Ambulatory Surgical Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Treatment Type:
Leukemia
Lymphoma
Myeloma
Myelodysplastic Syndrome
Myeloproliferative neoplasms
Aplastic Anemia
Solid Tumors
Sickle cell anemia
Thalassemia
Others
By End User
Hospitals
Multi-Specialty Clinics
Ambulatory Surgical Centers
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Treatment Type:
Leukemia
Lymphoma
Myeloma
Myelodysplastic Syndrome
Myeloproliferative neoplasms
Aplastic Anemia
Solid Tumors
Sickle cell anemia
Thalassemia
Others
By End User
Hospitals
Multi-Specialty Clinics
Ambulatory Surgical Centers
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Treatment Type:
Leukemia
Lymphoma
Myeloma
Myelodysplastic Syndrome
Myeloproliferative neoplasms
Aplastic Anemia
Solid Tumors
Sickle cell anemia
Thalassemia
Others
By End User
Hospitals
Multi-Specialty Clinics
Ambulatory Surgical Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Treatment Type:
Leukemia
Lymphoma
Myeloma
Myelodysplastic Syndrome
Myeloproliferative neoplasms
Aplastic Anemia
Solid Tumors
Sickle cell anemia
Thalassemia
Others
By End User
Hospitals
Multi-Specialty Clinics
Ambulatory Surgical Centers
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Lonza Group Ltd.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Merck Millipore Corporation
Sanofi-Aventis LLC
AllCells LLC
STEMCELL Technologies
American Type Culture Collection (ATCC) Inc.
“*” marked represents similar segmentation in other categories in the respective section.